International Journal of

Current Pharmaceutical Review and Research

ISSN: 0976 822X

Peer Review Journal

Disclimer: Scopus and Crossref are registered trademark of respective companies.

This journal is member of Crossref. 

Prakhar Gupta, Ashok Kumar Sharma, Dilip Agrawal, Mohit Khandelwal, Shaneza Aman, Shweta bhandari

Mucormycosis is one of the uncommon fungal contaminations, which has a high pace of bleakness and mortality. Its illness causing fungus is Mucormycetes and it has a place with the request Mucorales, subphylum Mucoromycotina. As the illness is uncommon, it is truly challenging to lead enormous, randomized clinical preliminaries. The information with respect to the study of disease transmission, finding, and treatment, is just made accessible through different case reports and case series. Mucormycotina saprobes are most ordinarily found in bad matter or soils. The board of the illnesses relies upon exact conclusion and brief treatment incorporating antifungal specialists alongside careful intercession with the elaborate tissues. Numerous new specialists with restorative impact against Mucorales are under assessment over chronicled and demonstrated first line treatment of amphotericin B-based medications or Posaconazole. Subsequently, in this article, I have summed up the insight concerning the mucormycosis i.e Dark Organism their sorts, beginning, treatment, determination, avoidances, various medications utilized for its treatment and their incidental effects. This audit shows an unmistakable outline of the Mucormycosis and its treatment.

Impact Factor: 1.041

Review and Reserach

This journal is peer Reviewed Journal